Mark Roithmayr to Retire from Alzheimer's Drug Discovery Foundation Leadership in 2025 Mark Roithmayr, CEO of the Alzheimer's Drug Discovery Foundation, has announced his retirement effective December 31, 2025, after nine transformative years.

Mark Roithmayr to Retire from Alzheimer's Drug Discovery Foundation Leadership in 2025 #USA #New_York #Alzheimer's_Drug #Mark_Roithmayr #ADDF